The healthcare community is buzzing by retatrutide, a innovative dual GIP and GLP-1 target that’s showing impressive results in clinical studies . This treatment works by mimicking natural hormones to impact appetite and increase feelings of satisfaction , ultimately contributing to substantial weight decrease. While presently under review and no